Categories: EHRNews

Coloplast A/S – Q1 2024/25 Earnings Release – Invitation to conference call on 4 February 2025 at 11.00am CET (correction)

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Tuesday, 4 February 2025 at 11.00 – 12.00am CET (corrected from 10.00 – 11.00am CET in an earlier version of this invitation)
In connection with the publication of Coloplast’s interim financial results for Q1 2024/25, to be released same day around 07.30am CET, Coloplast will host a conference call to present the financial results and answer questions from investors and financial analysts. A presentation will be available on Coloplast’s website approximately 1 hour before the conference call.
The webcast of the conference call will be available during and after the event. 

Coloplast will be represented by:
Kristian Villumsen – President & CEO
Anders Lonning-Skovgaard  Executive Vice President, CFO
Aleksandra Dimovska – Vice President, Investor Relations
Simone Dyrby Helvind – Senior Manager, Investor Relations 

 

Webcast
For participants who do not wish to actively participate in the Q&A session, please access the conference call as a webcast via the link below:
Access the webcast here


Dial-in details
To actively participate in the Q&A session, please sign up ahead of the conference call on the link below to receive an email with dial-in details.
Register for the conference call here

 

 

 

For more information, please contact:

Aleksandra Dimovska – Vice President, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 2458. E-mail: dkadim@coloplast.com

Simone Dyrby Helvind – Senior Manager, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 2981. E-mail: dksdk@coloplast.com

Julie Isabella Sommer Müggler – Coordinator & PA, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 3161. E-mail: dkjusm@coloplast.com

Coloplast will be available on individual phone lines after the conference call for further questions.

Attachment

Staff

Recent Posts

Lyra Growth Partners Inc. Announces Sale of Common Shares of BuildDirect.com Technologies Inc.

Vancouver, British Columbia--(Newsfile Corp. - May 28, 2025) - Lyra Growth Partners Inc. ("Lyra") announces…

2 hours ago

SCAN Named the Winner of the 2025 Hearst Health Prize

$100,000 Hearst Health Prize recognizes innovative initiatives using data science to make a health impact…

4 hours ago

Nanalysis Announces First Quarter 2025 Results

Delivers Another Quarter of Positive Adjusted EBITDA & Operating Cash Flow CALGARY, AB, May 28,…

4 hours ago

Veeva Announces Fiscal 2026 First Quarter Results

Total Revenues of $759.0M, up 17% Year Over YearSubscription Services Revenues of $634.8M, up 19%…

4 hours ago

Staffency, a TotalMed Company, Announces Merger with SimpliFi to Enhance Workforce Solutions

APPLETON, Wis., May 28, 2025 /PRNewswire/ -- Staffency, a premier workforce solutions provider and division…

4 hours ago

World-Renowned Mold Illness Expert Dr. Scott McMahon Joins MoldCo as Medical Director

Together, They Aim to Solve One of America's Most Overlooked Health Crisis: Mold Toxicity LOS…

4 hours ago